China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)
China
· Delayed Price · Currency is CNY 29.94
-0.13 (-0.43%)
Mar 10, 2026, 2:15 PM CST
SHE:000999 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | - | 3,368 | 2,853 | 2,449 | 2,055 | Upgrade
|
| Depreciation & Amortization | - | 723.19 | 786.67 | 522.66 | 478.75 | Upgrade
|
| Other Amortization | - | 177.07 | 67.11 | 48.75 | 45.84 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -31.43 | -0.81 | -2.28 | -0.85 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 19.72 | 88.97 | 99.81 | 52.33 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 5.08 | 28.63 | -2.58 | -5.04 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 82.87 | 55.04 | 5.53 | 13.63 | Upgrade
|
| Other Operating Activities | - | 564.05 | 467.94 | 102.6 | 200.43 | Upgrade
|
| Change in Accounts Receivable | - | -1,243 | 633.69 | -71.84 | -674.74 | Upgrade
|
| Change in Inventory | - | 67.83 | -966.01 | -59.69 | -652.26 | Upgrade
|
| Change in Accounts Payable | - | 682.7 | 315.29 | -21.86 | 458.43 | Upgrade
|
| Operating Cash Flow | - | 4,402 | 4,192 | 3,006 | 1,885 | Upgrade
|
| Operating Cash Flow Growth | - | 5.02% | 39.43% | 59.52% | -15.26% | Upgrade
|
| Capital Expenditures | - | -790.07 | -857.21 | -951.57 | -872.6 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 5.17 | 26.43 | 1.78 | 4.56 | Upgrade
|
| Cash Acquisitions | - | - | 953.63 | -11.76 | -120.63 | Upgrade
|
| Divestitures | - | - | 4.25 | - | - | Upgrade
|
| Investment in Securities | - | -424.16 | -953.36 | -1,584 | -870.37 | Upgrade
|
| Other Investing Activities | - | 78.65 | 32.77 | 66.4 | 66.74 | Upgrade
|
| Investing Cash Flow | - | -1,130 | -793.5 | -2,479 | -1,792 | Upgrade
|
| Long-Term Debt Issued | - | 1,007 | 3,578 | 593.69 | 97.97 | Upgrade
|
| Total Debt Issued | - | 1,007 | 3,578 | 593.69 | 97.97 | Upgrade
|
| Short-Term Debt Repaid | - | -4.2 | -17.05 | -1.45 | -3.1 | Upgrade
|
| Long-Term Debt Repaid | - | -2,771 | -1,930 | -520.27 | -105.43 | Upgrade
|
| Total Debt Repaid | - | -2,775 | -1,947 | -521.72 | -108.53 | Upgrade
|
| Net Debt Issued (Repaid) | - | -1,768 | 1,631 | 71.98 | -10.56 | Upgrade
|
| Issuance of Common Stock | - | 10 | - | 150.6 | 10.18 | Upgrade
|
| Repurchase of Common Stock | - | -2.21 | - | - | - | Upgrade
|
| Common Dividends Paid | - | -2,834 | -1,056 | -855.78 | -505.66 | Upgrade
|
| Other Financing Activities | - | -33.92 | -124.98 | 57.75 | -162.98 | Upgrade
|
| Financing Cash Flow | - | -4,629 | 450.42 | -575.45 | -669.02 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 2.88 | 5.01 | 6.35 | -2.31 | Upgrade
|
| Net Cash Flow | - | -1,354 | 3,854 | -41.93 | -578.98 | Upgrade
|
| Free Cash Flow | - | 3,612 | 3,335 | 2,055 | 1,012 | Upgrade
|
| Free Cash Flow Growth | - | 8.33% | 62.28% | 103.03% | -36.83% | Upgrade
|
| Free Cash Flow Margin | - | 13.08% | 13.48% | 11.37% | 6.51% | Upgrade
|
| Free Cash Flow Per Share | - | 2.17 | 2.00 | 1.23 | 0.61 | Upgrade
|
| Cash Income Tax Paid | - | 2,701 | 2,762 | 1,839 | 1,919 | Upgrade
|
| Levered Free Cash Flow | - | 2,540 | 149.87 | 1,534 | 73.83 | Upgrade
|
| Unlevered Free Cash Flow | - | 2,590 | 200.36 | 1,547 | 82.7 | Upgrade
|
| Change in Working Capital | - | -506.25 | -154.74 | -216.92 | -955.53 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.